STK11 and cancer: Adenosine monophosphate-activated protein kinase is considered neither an ally nor an adversary in the progression of cancer (143), and the upregulation of PI3K/Akt pathway with concomitant inhibition of PTEN in most cancers leads to LKB1 impairment in the activation of AMPK for its tumor suppression role (144).